Larotrectinib Sulfate

ATC L01EX12 · 3 markets · 9 records

Larotrectinib Sulfate 3 markets · 9 records Forms

CA 3 records · 3 strengths

100 mgcapsuleVITRAKVI also in SG
25 mgcapsuleVITRAKVI also in SG
20 mgliquidVITRAKVI

AU 3 records · 3 strengths

122.9 mgcapsuleVITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle unknown
30.7 mgcapsuleVITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle unknown
24.6 mg/mLliquidVITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle unknown

SG 3 records · 3 strengths

100 mgcapsuleVITRAKVI HARD CAPSULE 100MG also in CA
25 mgcapsuleVITRAKVI HARD CAPSULE 100MG also in CA
20 mg/mLliquidVitrakvi 20mg/ml oral solution

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.